Literature DB >> 25135713

Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of China.

Jian-Qiang Cai1, Shou-Wang Cai2, Wen-Ming Cong3, Min-Shan Chen4, Ping Chen5, Xiao-Ping Chen6, Yan-Ling Chen7, Yi-Fa Chen8, Chao-Liu Dai9, Qiang Huang10, Zhi-Yong Huang8, Bo Jiang11, Bin Jiang12, Ke-Wei Jiang13, Bo Li14, Zong-Fang Li15, Li-Jian Liang16, Bin Liu17, Hui-Chun Liu18, Lian-Xin Liu19, Qing-Guang Liu20, Rong Liu2, Ying-Bin Liu21, Jian-Guo Lu22, Shi-Chun Lu2, Yi Lu20, Yi-Lei Mao23, Bin Mei8, Jun Niu24, Bao-Gang Peng16, Xiao Qin25, Yu-Dong Qiu26, Guang-Yi Wang27, Yao-Dong Wang28, Zhi-Ming Wang29, Ren-Hua Wan30, Ya-Fu Wu26, Bao-Cai Xing31, Feng Xia32, Ge-Liang Xu10, Jia-Mei Yang3, Xiao-Fang Yu33, Yong Zeng14, Yong-Yi Zeng34, Bi-Xiang Zhang8, Bin-Hao Zhang8, Qi-Yu Zhang35, Shui-Jun Zhang36, Wan-Guang Zhang8, Yong-Jie Zhang3, Zhi-Wei Zhang8, Dong Zhou37, Wei-Ping Zhou3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25135713     DOI： 10.1007/s11596-014-1301-5

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN： 1672-0733


× No keyword cloud information.
  25 in total

1.  Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.

Authors:  T S Yeh; Y Y Jan; J H Tseng; C T Chiu; T C Chen; T L Hwang; M F Chen
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 2.  Treatment options for other hepatic malignancies.

Authors:  J G O'Grady
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

Review 3.  Early detection and treatment of cholangiocarcinoma.

Authors:  G J Gores
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

4.  The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors:  A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

5.  A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis.

Authors:  R Hultcrantz; R Olsson; A Danielsson; G Järnerot; L Lööf; B O Ryden; B Wahren; U Broomé
Journal:  J Hepatol       Date:  1999-04       Impact factor: 25.083

6.  Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy.

Authors:  G Torzilli; M Minagawa; T Takayama; K Inoue; A M Hui; K Kubota; K Ohtomo; M Makuuchi
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

Review 7.  Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging.

Authors:  B S Kuszyk; P Soyer; D A Bluemke; E K Fishman
Journal:  Crit Rev Diagn Imaging       Date:  1997

8.  HASTE MR cholangiography in the evaluation of hilar cholangiocarcinoma.

Authors:  A S Fulcher; M A Turner
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959

9.  Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.

Authors:  S H Zidi; F Prat; O Le Guen; Y Rondeau; G Pelletier
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

10.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  J K Ramage; A Donaghy; J M Farrant; R Iorns; R Williams
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682
View more
  8 in total

1.  Comprehensive analysis of competing endogenous RNA networks associated with cholangiocarcinoma.

Authors:  Fangting Xu; Yuchong Zhao; Gang Qin; Ye Huan; Longyan Li; Wei Gao
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

2.  Mechanism of dynamic near-infrared fluorescence cholangiography of extrahepatic bile ducts and applications in detecting bile duct injuries using indocyanine green in animal models.

Authors:  Yang Gao; Min Li; Zi-Fang Song; Le Cui; Bi-Rong Wang; Xiao-Ding Lou; Tao Zhou; Yong Zhang; Qi-Chang Zheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-02-22

3.  First Reported Case of Primary Intrahepatic Cholangiocarcinoma with Pure Squamous Cell Histology: A Case Report.

Authors:  Sandeep Singh Lubana; Navdeep Singh; Barbara Seligman; Sandeep S Tuli; David M Heimann
Journal:  Am J Case Rep       Date:  2015-07-09

4.  Fyn knockdown inhibits migration and invasion in cholangiocarcinoma through the activated AMPK/mTOR signaling pathway.

Authors:  Shao-Cheng Lyu; Dong-Dong Han; Xian-Liang Li; Jun Ma; Qiao Wu; Hong-Meng Dong; Chun Bai; Qiang He
Journal:  Oncol Lett       Date:  2017-12-07       Impact factor: 2.967

5.  The effect and safety of preoperative biliary drainage in patients with hilar cholangiocarcinoma: an updated meta-analysis.

Authors:  Fei Teng; You-Yin Tang; Jun-Long Dai; Yongkun Li; Zhe-Yu Chen
Journal:  World J Surg Oncol       Date:  2020-07-18       Impact factor: 2.754

Review 6.  Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation II (AGREE II) Instrument.

Authors:  Paschalis Gavriilidis; Alan Askari; Keith J Roberts; Robert P Sutcliffe
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

7.  Primary Intrahepatic Squamous Cell Carcinoma with Histological Collision of Adenocarcinoma and Squamous Cell Carcinoma: A Case Report.

Authors:  Kohei Tamaoka; Masahiro Tanemura; Kenta Furukawa; Manabu Mikamori; Takuro Saito; Masahisa Ohtsuka; Yozo Suzuki; Mitsuyoshi Tei; Kentaro Kishi; Hironao Yasuoka; Masahiko Tsujimoto; Hiroki Akamatsu
Journal:  Am J Case Rep       Date:  2018-10-05

8.  Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade.

Authors:  Xiaoliang Liu; Jianfei Yao; Lele Song; Sujing Zhang; Tanxiao Huang; Yu Li
Journal:  J Immunother Cancer       Date:  2019-08-05       Impact factor: 12.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.